Table 2.

The relationship between patient-related factors, overall survival, and disease-free survival in patients undergoing potentially curative resection for gastric cancer

Clinicopathological variables	Frequency n (%)	Disease-free survival	p value	Overall survival	p value
		5-year survival rate (%)		5-year survival rate (%)
Age (years)
< 65	99 (34.0)	62.1	0.053	51.5	0.714
65–75	121 (41.6)	67.5		45.8
> 75 years	71 (24.4)	83.0		44.7
Sex
Female	97 (33.3)	61.5	0.093	38.5	0.076
Male	194 (66.7)	73.3		51.9
White cell count
Low	205 (70.4)	68.6	0.938	46.7	0.823
Normal	63 (21.6)	71.1		51.1
High	23 (7.9)	71.4		42.9
Neutrophil count
Low	264 (90.7)	68.7	0.507	46.4	0.326
High	27 (9.3)	76.5		58.8
Lymphocyte count
Low	27 (9.3)	70.6	0.908	29.4	0.236
Normal	250 (85.9)	69.6		49.7
High	14 (4.8)	62.5		37.5
Platelet count
Low	260 (89.3)	71.3	0.109	49.6	0.119
High	31 (10.7)	54.5		31.8
C-reactive protein
Normal	231 (79.4)	73.4	0.020	51.9	0.016
High	60 (20.6)	54.8		31.0
Albumin
Normal	219 (75.3)	70.1	0.680	49.7	0.209
Low	72 (24.7)	66.7		38.5
Derivative markers
Neutrophil-lymphocyte
Ratio
Low	261 (89.7)	70.7	0.266	47.1	0.800
High	30 (10.3)	59.1		50.0
Neutrophil-platelet score
Low	239 (82.1)	71.4	0.075	49.7	0.011
Intermediate	46 (15.8)	54.8		29.0
High	6 (2.1)	100.0		100.0
Platelet-lymphocyte
Ratio
Low	143 (49.1)	73.5	0.215	54.1	0.063
High	148 (50.9)	65.3		40.8
Modified Glasgow Prognostic Score
Low	231 (79.4)	73.4	0.044	51.9	0.015
Intermediate	31 (10.7)	52.2		34.8
High	29 (10.0)	57.9		26.3